Russia
Industry
The Federal Antimonopoly Service's decision, to block a proposed merger between Abbott Laboratories Petrovax Pharm, while unexpected, does not signal a worsening investment climate...
2013-04-22Industry
BMI View: Moves by Russia's Ministry of Industry and Trade to liberalise the over-the-counter (OTC) medicine sector are coming to fruition, with the Health Ministry having the final...
2013-04-03Industry
BMI View: While drug imports may have declined in 2012, we believe the innovation gap between multinational and Russian drugmakers will continue to favour the multinationals. Russia's...
2013-03-22Industry
BMI View: While the Russian state has enacted drastic changes that increase contributions from citizens towards the cost of healthcare, its guarantees towards pensioners, whose numbers...
2013-03-15Industry
BMI View: Indian drugmakers recognising the growth potential of the Russian market are continuing their pursuit of localising production in the country. Strong historic and geopolitical...
2013-03-14Industry
BMI View: Pharmaceutical companies have typically targeted Russian state and regional procurement bids for expensive medicines as their revenue earners in the market. This is despite...
2013-03-08Industry
BMI View: The recent escalation in the tussle over imatinib highlights the need for Russian authorities to reform the Ministry of Health, public procurement and competition laws. The...
2013-02-25Industry
BMI View: The recent change to Russia's reference pricing mechanism contradicts the government's goals for the domestic pharmaceutical industry. Introducing India and China as reference...
2013-02-14
